Dynavax Technologies Corporation (DVAX)
Feb 10, 2026 - DVAX was delisted (reason: acquired by SNY)
15.50
0.00 (0.00%)
Inactive · Last trade price on Feb 9, 2026
Dynavax Technologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -43.4 | 27.31 | -6.39 | 293.16 | 76.71 | -75.24 |
Depreciation & Amortization | 4.89 | 4.63 | 4.34 | 3.81 | 4.3 | 4.27 |
Stock-Based Compensation | 52.83 | 52.62 | 42.59 | 32.92 | 21.29 | 13.48 |
Other Adjustments | 2.87 | -2.01 | -1.19 | 31.25 | 61.01 | -1.85 |
Change in Receivables | 1.96 | -2.37 | 43.27 | -15.7 | -109.16 | -13.78 |
Changes in Inventories | -16.41 | -19.91 | 3.91 | -32.4 | -0.23 | -22.36 |
Changes in Accounts Payable | -3.27 | 3.9 | 1.95 | 0.69 | -0.77 | -0.23 |
Changes in Accrued Expenses | -3.82 | 6.65 | 16.18 | -27.91 | 36.49 | 38.21 |
Changes in Unearned Revenue | - | - | - | -349.86 | 311.65 | -2.87 |
Changes in Other Operating Activities | -2.73 | -4.3 | -4.1 | 126.77 | -65.77 | -31.89 |
Operating Cash Flow | 90.63 | 66.51 | 100.56 | 62.72 | 335.53 | -92.25 |
Operating Cash Flow Growth | 232.39% | -33.86% | 60.35% | -81.31% | - | - |
Capital Expenditures | -10.1 | -6.35 | -4.1 | -7.14 | -9.48 | -4.07 |
Sale of Property, Plant & Equipment | - | - | 1 | 1 | 1 | 6.85 |
Purchases of Intangible Assets | - | - | - | - | - | -7 |
Purchases of Investments | -284.67 | -524.06 | -636.92 | -632.31 | -164.93 | -201.79 |
Proceeds from Sale of Investments | 447.16 | 512.38 | 486.1 | 322.45 | 187.63 | 179.48 |
Investing Cash Flow | 152.39 | -18.04 | -153.93 | -316 | 14.23 | -26.53 |
Long-Term Debt Issued | - | - | - | - | 219.82 | - |
Long-Term Debt Repaid | - | - | - | - | -190.19 | - |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | 29.63 | - |
Issuance of Common Stock | 10.78 | 7.29 | 7.9 | 19.53 | 53.39 | 109.5 |
Repurchase of Common Stock | -213.5 | -109.31 | -6.51 | - | - | - |
Net Common Stock Issued (Repurchased) | -202.71 | -102.02 | 1.39 | 19.53 | 53.39 | 109.5 |
Other Financing Activities | - | - | - | - | -27.24 | - |
Financing Cash Flow | -202.74 | -102.02 | 1.39 | 19.53 | 55.78 | 109.5 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.65 | -0.86 | 0.32 | -0.44 | -1.43 | 1.49 |
Net Cash Flow | 40.94 | -54.4 | -51.66 | -234.2 | 404.1 | -7.79 |
Beginning Cash & Cash Equivalents | 119.61 | 150.56 | 202.21 | 436.41 | 32.31 | 40.1 |
Free Cash Flow | 80.54 | 60.16 | 96.46 | 55.58 | 326.05 | -96.32 |
Free Cash Flow Growth | 33.87% | -37.63% | 73.56% | -82.95% | - | - |
FCF Margin | 24.37% | 21.70% | 41.53% | 7.69% | 74.20% | -206.92% |
Free Cash Flow Per Share | 0.58 | 0.45 | 0.75 | 0.37 | 2.45 | -0.95 |
Levered Free Cash Flow | 10.06 | 11.92 | 11.79 | 6.83 | 377.97 | -94.18 |
Unlevered Free Cash Flow | -20.99 | -19.04 | -36 | -3.62 | 409.28 | -87.31 |